Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.42 -0.07 (-4.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Sale and Maturity of Investments (2010 - 2026)

Updated

Analysis

Lexicon Pharmaceuticals (LXRX) Sale and Maturity of Investments (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Lexicon Pharmaceuticals 634.56 Mn 61.11 Mn 653,000.00 40.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.80 Mn
Mar 31, 2026 35.70 Mn
Dec 31, 2025 27.00 Mn
Sep 30, 2025 78.85 Mn
Jun 30, 2025 41.46 Mn
Mar 31, 2025 105.55 Mn
Dec 31, 2024 80.00 Mn
Sep 30, 2024 96.40 Mn
Jun 30, 2024 65.00 Mn
Mar 31, 2024 73.00 Mn
Dec 31, 2023 52.00 Mn
Sep 30, 2023 33.00 Mn
Jun 30, 2023 47.67 Mn
Mar 31, 2023 41.21 Mn
Dec 31, 2022 26.01 Mn
Sep 30, 2022 16.00 Mn
Jun 30, 2022 8.71 Mn
Mar 31, 2022 13.48 Mn
Dec 31, 2021 11.50 Mn
Sep 30, 2021 4.32 Mn
API Access

Lexicon Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=LXRX&period=max&api_key=YOUR_API_KEY